Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update
Verona Pharma plc (Nasdaq: VRNA) has announced it will report its financial results for the third quarter ended September 30, 2024 on Monday, November 4, 2024. The company will also host an investment community conference call at 9:00 a.m. EDT / 2:00 p.m. GMT to discuss these financial results and provide a corporate update.
To participate in the call, investors can dial +1-833-816-1396 (US callers) or +1-412-317-0489 (international callers) and ask to join the Verona Pharma call. A live webcast will be available on the Events and Presentations link on the Investors page of the company's website, www.veronapharma.com, with an audio replay available for 90 days.
Verona Pharma plc (Nasdaq: VRNA) ha annunciato che riporterà i suoi risultati finanziari per il terzo trimestre chiuso il 30 settembre 2024 lunedì 4 novembre 2024. L'azienda ospiterà anche una conference call per la comunità degli investitori alle 9:00 EDT / 14:00 GMT per discutere questi risultati finanziari e fornire un aggiornamento aziendale.
Per partecipare alla chiamata, gli investitori possono comporre il numero +1-833-816-1396 (chiamate dagli Stati Uniti) o +1-412-317-0489 (chiamate internazionali) e chiedere di unirsi alla chiamata di Verona Pharma. Un webcast in diretta sarà disponibile nel link Eventi e Presentazioni nella pagina Investitori del sito web dell'azienda, www.veronapharma.com, con una registrazione audio disponibile per 90 giorni.
Verona Pharma plc (Nasdaq: VRNA) ha anunciado que informará sobre sus resultados financieros para el tercer trimestre que finalizó el 30 de septiembre de 2024 el lunes 4 de noviembre de 2024. La compañía también llevará a cabo una conferencia telefónica con la comunidad inversora a las 9:00 a.m. EDT / 2:00 p.m. GMT para discutir estos resultados financieros y proporcionar una actualización corporativa.
Para participar en la llamada, los inversores pueden marcar +1-833-816-1396 (llamadas de EE. UU.) o +1-412-317-0489 (llamadas internacionales) y pedir unirse a la llamada de Verona Pharma. Un webcast en vivo estará disponible en el enlace de Eventos y Presentaciones en la página de Inversores del sitio web de la empresa, www.veronapharma.com, con una reproducción de audio disponible durante 90 días.
베로나 제약 plc (Nasdaq: VRNA)는 2024년 9월 30일로 종료된 3분기 재무 결과를 2024년 11월 4일 월요일에 발표할 것이라고 발표했습니다. 회사는 이러한 재무 결과를 논의하고 기업 업데이트를 제공하는 투자자 커뮤니티 컨퍼런스 콜을 EDT 기준 오전 9시/ GMT 기준 오후 2시에 실시합니다.
콜에 참여하려면 투자자는 +1-833-816-1396 (미국 발신자) 또는 +1-412-317-0489 (국제 발신자)로 전화하여 베로나 제약 콜에 참여하고 싶다고 요청할 수 있습니다. 실시간 웹캐스트는 회사 웹사이트 www.veronapharma.com의 투자자 페이지 내 이벤트 및 프레젠테이션 링크에서 이용 가능하며, 90일간 오디오 재생이 가능합니다.
Verona Pharma plc (Nasdaq: VRNA) a annoncé qu'elle publiera ses résultats financiers pour le troisième trimestre clos le 30 septembre 2024 le lundi 4 novembre 2024. L'entreprise tiendra également une conférence téléphonique avec la communauté des investisseurs à 9h00 EDT / 14h00 GMT pour discuter de ces résultats financiers et fournir une mise à jour sur l'entreprise.
Pour participer à l'appel, les investisseurs peuvent composer le +1-833-816-1396 (appelants des États-Unis) ou le +1-412-317-0489 (appelants internationaux) et demander à rejoindre l'appel de Verona Pharma. Un webinaire en direct sera disponible sur le lien Événements et Présentations de la page Investisseurs du site Web de la société, www.veronapharma.com, avec une rediffusion audio disponible pendant 90 jours.
Verona Pharma plc (Nasdaq: VRNA) hat bekannt gegeben, dass es seine finanziellen Ergebnisse für das dritte Quartal zum 30. September 2024 am Montag, den 4. November 2024 veröffentlichen wird. Das Unternehmen wird auch eine Telefonkonferenz mit der Investoren-Community um 9:00 Uhr EDT / 14:00 Uhr GMT abhalten, um diese finanziellen Ergebnisse zu besprechen und ein Unternehmensupdate zu geben.
Um an der Konferenz teilzunehmen, können Investoren die Nummer +1-833-816-1396 (Anrufer aus den USA) oder +1-412-317-0489 (internationale Anrufer) wählen und um Teilnahme an der Verona Pharma-Konferenz bitten. Ein Live-Webcast wird auf dem Link Veranstaltungen und Präsentationen auf der Investoren-Seite der Unternehmenswebsite, www.veronapharma.com, verfügbar sein, und eine Audio-Wiedergabe wird für 90 Tage verfügbar sein.
- None.
- None.
LONDON and RALEIGH, N.C., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that it will report its financial results for the third quarter ended September 30, 2024 on Monday, November 4, 2024 and host an investment community conference call at 9:00 a.m. EDT / 2:00 p.m. GMT to discuss these financial results and provide a corporate update.
To participate, please dial one of the following numbers and ask to join the Verona Pharma call:
- +1-833-816-1396 for callers in the United States
- +1-412-317-0489 for international callers
A live webcast will be available on the Events and Presentations link on the Investors page of the Company’s website, www.veronapharma.com, and the audio replay will be available for 90 days.
For further information please contact:
| Verona Pharma plc | Tel: +1-844-341-9901 |
| Victoria Stewart, Senior Director of Investor Relations and Communications | IR@veronapharma.com |
| Argot Partners US Investor Enquiries | Tel: +1-212-600-1902 verona@argotpartners.com |
| Ten Bridge Communications International / US Media Enquiries | Tel: +1-312-523-5016 tbcverona@tenbridgecommunications.com |
| Leslie Humbel |
About Verona Pharma
Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. Ohtuvayre™ (ensifentrine) is the Company’s first commercial product and the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule. Ensifentrine has potential applications in non-cystic fibrosis bronchiectasis, cystic fibrosis, asthma and other respiratory diseases. For more information, please visit www.veronapharma.com.
FAQ
When will Verona Pharma (VRNA) report its Q3 2024 financial results?
What time is Verona Pharma's (VRNA) Q3 2024 earnings call scheduled for?
How can investors participate in Verona Pharma's (VRNA) Q3 2024 earnings call?
Where can I find the webcast for Verona Pharma's (VRNA) Q3 2024 earnings call?
